JP2013540778A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540778A5
JP2013540778A5 JP2013535207A JP2013535207A JP2013540778A5 JP 2013540778 A5 JP2013540778 A5 JP 2013540778A5 JP 2013535207 A JP2013535207 A JP 2013535207A JP 2013535207 A JP2013535207 A JP 2013535207A JP 2013540778 A5 JP2013540778 A5 JP 2013540778A5
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutically acceptable
therapeutic agent
prodrug
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013535207A
Other languages
English (en)
Japanese (ja)
Other versions
JP6184866B2 (ja
JP2013540778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2011/001376 external-priority patent/WO2012054978A1/en
Publication of JP2013540778A publication Critical patent/JP2013540778A/ja
Publication of JP2013540778A5 publication Critical patent/JP2013540778A5/ja
Application granted granted Critical
Publication of JP6184866B2 publication Critical patent/JP6184866B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013535207A 2010-10-27 2011-10-27 新規抗がん剤 Expired - Fee Related JP6184866B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40726510P 2010-10-27 2010-10-27
US61/407,265 2010-10-27
PCT/AU2011/001376 WO2012054978A1 (en) 2010-10-27 2011-10-27 Novel anti-cancer agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017037462A Division JP2017137323A (ja) 2010-10-27 2017-02-28 新規抗がん剤

Publications (3)

Publication Number Publication Date
JP2013540778A JP2013540778A (ja) 2013-11-07
JP2013540778A5 true JP2013540778A5 (cg-RX-API-DMAC7.html) 2014-12-11
JP6184866B2 JP6184866B2 (ja) 2017-08-23

Family

ID=45992970

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535207A Expired - Fee Related JP6184866B2 (ja) 2010-10-27 2011-10-27 新規抗がん剤
JP2017037462A Pending JP2017137323A (ja) 2010-10-27 2017-02-28 新規抗がん剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017037462A Pending JP2017137323A (ja) 2010-10-27 2017-02-28 新規抗がん剤

Country Status (12)

Country Link
US (3) US8835629B2 (cg-RX-API-DMAC7.html)
EP (1) EP2632916B1 (cg-RX-API-DMAC7.html)
JP (2) JP6184866B2 (cg-RX-API-DMAC7.html)
KR (1) KR101896924B1 (cg-RX-API-DMAC7.html)
CN (1) CN103476769B (cg-RX-API-DMAC7.html)
AU (1) AU2011320024B2 (cg-RX-API-DMAC7.html)
CA (1) CA2814120C (cg-RX-API-DMAC7.html)
ES (1) ES2621932T3 (cg-RX-API-DMAC7.html)
HU (1) HUE032522T2 (cg-RX-API-DMAC7.html)
NZ (1) NZ609186A (cg-RX-API-DMAC7.html)
PL (1) PL2632916T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012054978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103476769B (zh) * 2010-10-27 2016-06-01 沃尔特及伊莱萨霍尔医学研究院 抗癌剂
KR101853785B1 (ko) 2013-11-20 2018-05-02 주식회사 만도 3상모터 제어장치 및 그의 고토크 유지 방법
WO2016070241A1 (en) * 2014-11-03 2016-05-12 Ctxt Pty Ltd Triazine compounds, compositions and synthesis
US20200128829A1 (en) * 2017-06-08 2020-04-30 University Of South Alabama Antimicrobial Compounds
JP7510347B2 (ja) 2018-01-17 2024-07-03 オーリジーン オンコロジー リミテッド 抗癌剤としての置換されたアルキニレン化合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2742466A (en) 1956-04-17 Chx n nhx c c
GB1035771A (cg-RX-API-DMAC7.html)
US3145203A (en) 1961-11-30 1964-08-18 Geigy Chem Corp Hydrazones of 5-nitro-2-furaldehyde
JPS5277163A (en) 1975-12-24 1977-06-29 Asahi Chem Ind Co Ltd Stabilized polyurethane composition
FR2524467A1 (fr) 1982-03-30 1983-10-07 Adir Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
JPS62192474A (ja) 1986-02-19 1987-08-24 Canon Inc 記録液
US4932998A (en) 1986-09-30 1990-06-12 Idemitsu Kosan Company Limited Triazine derivatives, and herbicides comprising the same as the effective ingredient
US4844731A (en) 1986-12-27 1989-07-04 Idemitsu Company Co., Ltd. Triazine derivatives
US5187045A (en) 1988-09-07 1993-02-16 Minnesota Mining And Manufacturing Company Halomethyl-1,3,5-triazines containing a sensitizer moiety
CA2027562C (en) 1989-02-20 1994-05-10 Masahiro Nishii Triazine derivative and a herbicide comprising the same as an effective ingredient
JPH07506084A (ja) 1991-11-12 1995-07-06 ファイザー インク. 抗腫瘍活性増強用のトリアジン誘導体
WO1993017009A1 (fr) 1992-02-28 1993-09-02 Zenyaku Kogyo Kabushiki Kaisha DERIVE DE s-TRIAZINE ET REMEDE CONTRE DES MALADIES DEPENDENTES DE L'×STROGENE LE CONTENANT COMME INGREDIENT ACTIF
US5574057A (en) * 1993-02-03 1996-11-12 University Of Utah Research Foundation Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
US6566384B1 (en) 1996-08-07 2003-05-20 Darwin Discovery Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
FR2757056B1 (fr) 1996-12-17 2003-03-14 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un compose amide et utilisations
FR2757057A1 (fr) 1996-12-17 1998-06-19 Oreal Compositions comprenant un derive de dibenzoylmethane, un derive de 1,3,5-triazine et un derive silicie a fonction benzalmalonate et utilisations
EP0945447A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
PT1333833E (pt) * 2000-10-23 2011-12-09 Glaxosmithkline Llc Novo composto 8h-pirido[2,3-d]pirimidin-7-ona trissusbtituída para o tratamento de doenças mediadas por csbp/p38 cinase
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
WO2003032903A2 (en) 2001-10-12 2003-04-24 New York University Trisubstituted triazines compounds with antitubulin activity
CN1697831A (zh) * 2002-09-23 2005-11-16 雷迪美国治疗公司 新三嗪化合物的制备方法和组合物
CN103476769B (zh) * 2010-10-27 2016-06-01 沃尔特及伊莱萨霍尔医学研究院 抗癌剂

Similar Documents

Publication Publication Date Title
PH12015502628B1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
PH12015501517A1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
MX2015016344A (es) Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
MX2015012432A (es) Inhibidores piridinicos de la cinasa cdk9.
JP2016501221A5 (cg-RX-API-DMAC7.html)
MX2014014106A (es) Derivados de acido 7-oxo-tiazolopiridinocarbonico y su uso en el tratamiento, disminucion o prevencion de una enfermedad viral.
JP2012255026A5 (cg-RX-API-DMAC7.html)
MX2014012695A (es) Derivados de isoindolona.
JP2013014622A5 (cg-RX-API-DMAC7.html)
EA201490419A1 (ru) Соединения для лечения и профилактики респираторного синцитиального вирусного заболевания
UA115320C2 (uk) Інгібітори кінази
JP2017537066A5 (cg-RX-API-DMAC7.html)
JP2013522326A5 (cg-RX-API-DMAC7.html)
IN2015DN01119A (cg-RX-API-DMAC7.html)
MX2015016425A (es) Derivados de pirazolo-pirrolidin-4-ona y su uso en el tratamiento de enfermedades.
MX377202B (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.
MX2014003803A (es) Derivados de acido heteroarilo hidroxamico y su uso en el tratamiento, mejora o prevencion de una enfermedad viral.
JP2014509653A5 (cg-RX-API-DMAC7.html)
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
JP2013540778A5 (cg-RX-API-DMAC7.html)
MX390763B (es) Compuestos de tetraciclina
MX2014003701A (es) Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio.
MX2015012386A (es) Inhibidores de la cinasa cdk9.